- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Pricing
- SKY Learn
- Mutual Funds
- Margin Trading
- Financial Planning
- Personal Finance
- Share Trading
- IPO
- Derivatives
- Currencies
- Intraday Trading
- Trading Strategies
- Demat Account
- Commodity
- ETF
Accretion Nutraveda IPO
₹1,22,000/1,000 shares
Minimum Investment
IPO Details
28 Jan 26
30 Jan 26
₹1,22,000
1,000
₹122 to ₹129
BSE
₹25 Cr
04 Feb 26
Accretion Nutraveda IPO Timeline
Bidding Start
28 Jan 26
Bidding Ends
30 Jan 26
Allotment Finalisation
02 Feb 26
Refund Initiation
03 Feb 26
Demat Transfer
03 Feb 26
Listing
04 Feb 26
Accretion Nutraveda Limited
Incorporated in 2021, Accretion Nutraveda manufactures Ayurvedic and nutraceutical products in tablets, capsules, powders, oral liquids, oils, and topical preparations. The company operates as a CDMO serving domestic and international markets, including Sri Lanka, Singapore, and the USA. Its offerings combine classical Ayurvedic principles with modern nutraceutical science, focusing on liver care, women’s health, bone and joint wellness, cognitive support, and respiratory health. Accretion Nutraveda’s manufacturing facility in Gujarat spans 10,763 sq. ft., equipped with advanced infrastructure and multiple quality certifications.
Accretion Nutraveda Limited IPO Overview
Accretion Nutraveda IPO opens on 27 January 2026 and closes on 30 January 2026, offering 19,20,000 shares at a price band of ₹122–₹129 per share. The IPO is entirely a fresh issue aggregating ₹24.77 Crore. The minimum lot size for retail investors is 1,000 shares, requiring ₹2,58,000. HNI investors can apply for a minimum of 3 lots (3,000 shares). Sobhagya Capital Options Pvt. Ltd. is the book running lead manager, and Kfin Technologies Ltd. is the registrar. Listing is planned on BSE SME on 4 February 2026. The allotment is expected on 2 February 2026, and refunds on 3 February 2026.
Accretion Nutraveda Limited IPO Details
| Particulars | Details |
| IPO Date | 27 to 30 Jan, 2026 |
| Listing Date | 4 Feb 2026 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹122 to ₹129 |
| Lot Size | 1,000 Shares |
| Total Issue Size | 19,20,000 shares (up to ₹24.77 Cr) |
| Fresh Issue | 19,20,000 shares (up to ₹24.77 Cr) |
| Offer for Sale | NA |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 53,20,000 shares |
| Share Holding Post Issue | 72,40,000 shares |
| Market Maker Portion | 96,000 shares |
Accretion Nutraveda Limited IPO Reservation
| Investor Category | Shares Offered |
| Market Maker | 96,000 (5.00%) |
| QIB | 9,08,000 (47.29%) |
| NII (HNI) | 2,76,000 (14.37%) |
| Retail | 6,40,000 (33.33%) |
| Total | 19,20,000 (100%) |
Accretion Nutraveda Limited IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 2 | 2,000 | ₹2,58,000 |
| Retail (Max) | 2 | 2,000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,32,000 |
Accretion Nutraveda Limited IPO Promoter Holding
| Shareholding Status | Percentage |
| Pre-Issue | 100% |
| Post-Issue | 73.48% |
Accretion Nutraveda Limited IPO Valuation Overview
| KPI | Value |
| Earnings Per Share (EPS) | 7.19 |
| Price/Earnings (P/E) Ratio | 35.75 |
| Return on Net Worth (RoNW) | 48.85% |
| Net Asset Value (NAV) | 14.72 |
| Return on Equity | 81.22% |
| Return on Capital Employed (ROCE) | 36.98% |
| EBITDA Margin | 22.79% |
| PAT Margin | 16.33% |
| Debt to Equity Ratio | 0.72 |
Objectives of the Proceeds
- Purchase machinery for automation in current manufacturing unit – ₹4.22 Cr
- Purchase machinery for new manufacturing setup – ₹8.03 Cr
- Fund working capital requirements – ₹5.50 Cr
- General corporate purposes
Key Financials (₹ Crore)
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 10.86 | 4.64 | 4.06 |
| Revenue | 16.06 | 5.20 | 3.07 |
| Profit After Tax | 2.61 | 0.82 | 0.28 |
| Reserves and Surplus | 4.86 | 0.72 | -0.10 |
| Total Borrowings | 3.86 | 2.17 | 1.97 |
SWOT Analysis of Accretion Nutraveda IPO
Strength and Opportunities
- Experienced promoters and management team.
- Diverse product portfolio across dosage forms
- Established domestic and international client base
- Strong quality standards and certifications
- Strategically located modern manufacturing facility
- Growing global demand for Ayurvedic products
Risks and Threats
- Highly competitive nutraceutical industry.
- Regulatory approvals may delay product launches
- Dependent on third-party suppliers for key raw materials
- Market demand fluctuations may affect revenue
- Limited brand recognition compared to established peers
- Currency fluctuations impacting export earnings
Explore IPO Opportunities
Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
About Accretion Nutraveda Limited
IPO Strengths of Accretion Nutraveda Limited
- Promoters and management team possess extensive experience and technical expertise.
- Well-established presence in domestic and international markets.
- Maintains long-term client relationships with consistent repeat business.
- Strong and reliable supplier network supporting operations.
- Large, integrated manufacturing facility strategically located for operational efficiency.
- Adheres to quality standards with recognized certifications and accreditations.
Peer Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (₹) | P/E (x) | RoNW (%) | P/BV Ratio |
| Accretion Nutraveda Ltd. | 7.19 | 7.19 | 14.72 | – | 48.85 | – |
| Peer Group | ||||||
| Walpar Nutritions Ltd. | 1.80 | 1.80 | 13.65 | 23.94 | 11.27 | 3.31 |
| Influx Healthtech Ltd. | 7.31 | 7.31 | 5.31 | 25.93 | 36.72 | 37.80 |
How to apply IPO with HDFC SKY?
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
FAQs On Accretion Nutraveda IPO
How can I apply for Accretion Nutraveda IPO?
Applications can be made via HDFC SKY using UPI-based ASBA.
What is the minimum investment for retail investors?
Retail investors must apply for at least 2,000 shares, approximately ₹2,58,000.
When will Accretion Nutraveda IPO shares be listed?
The IPO shares are expected to be listed on BSE SME on 4 February 2026.
Who is the registrar for Accretion Nutraveda IPO?
Kfin Technologies Ltd. is the registrar for this IPO.
By signing up I certify terms, conditions & privacy policy